Related Experiment Videos

[Treatment of cardiomyopathy using Ca blockers]

A Matsumori, M Tominaga, C Kawai

Nihon Rinsho. Japanese Journal of Clinical Medicine

|August 1, 1989

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Lessons learned from experimental myocarditis.

Herz·2012

Increased serum N-terminal pro-B-type natriuretic peptide and left ventricle diastolic dysfunction in patients with hepatitis C virus infection.

Journal of viral hepatitis·2012

HLA-DPbeta chain may confer the susceptibility to hepatitis C virus-associated hypertrophic cardiomyopathy.

International journal of immunogenetics·2008

Role of hepatitis C virus in cardiomyopathies.

Ernst Schering Research Foundation workshop·2005

The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III-class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy.

Tissue antigens·2005

Gene transfer of Fc-fusion cytokine by in vivo electroporation: application to gene therapy for viral myocarditis.

Gene therapy·2002

See all related articles